Obesity, Non-alcoholic Fatty Liver Disease research hub

Effects of extensive Weight loss on Insulin resistance and Lipid-kinetics in people with obesity and fatty liver Disease

This study looks at how a weight-loss drug, Wegovy, affects fat in the blood and liver in people with obesity and fatty liver disease. Researchers want to see if losing weight helps improve these conditions.